(Reuters) -GSK on Wednesday said its vaccine for the respiratory syncytial virus (RSV), which recently won EU approval, showed strong long-term protection in older adults in a late-stage trial. The …
Tag:
gsk’s
-
-
By Natalie Grover LONDON -British drugmaker GSK has struck a deal to allow low-cost generic versions of its long-acting HIV preventive medicine to be used in the developing world, including …
-
By Siddharth Cavale – Unilever faces a dilemma after its 50 billion pound ($68 billion) offer for GlaxoSmithKline’s consumer healthcare assets was rejected — should it raise the bid and …
-
– Unilever Plc has held talks with banks about additional financing for a potential sweetened offer for GlaxoSmithKline Plc’s consumer products division, Bloomberg reported https://www.bloomberg.com/news/articles/2022-01-16/unilever-is-said-to-weigh-raising-offer-for-glaxo-consumer-unit?sref=WJKVI5nK on Sunday, citing people familiar …